Verbeelen D - Search Results

1

Hemodynamics of patients with renal failure treated with recombinant human erythropoietin.

Verbeelen D, Bossuyt A, Smitz J, Herman A, Dratwa M, Jonckheer MH. Verbeelen D, et al. Clin Nephrol. 1989 Jan;31(1):6-11. Clin Nephrol. 1989. PMID: 2914412

2

Monitoring of bone mineral content in patients on regular hemodialysis.

Eeckhout E, Verbeelen D, Sennesael J, Kaufman L, Jonckheer MH. Eeckhout E, et al. Among authors: verbeelen d. Nephron. 1989;52(2):158-61. doi: 10.1159/000185620. Nephron. 1989. PMID: 2739850

3

Acceptability of rilmenidine and long-term surveillance of plasma concentrations in hypertensive patients with renal insufficiency.

Lins RL, Daelemans R, Dratwa M, Verbeelen D, Sennesael J, Brisgand B, Lameire N. Lins RL, et al. Among authors: verbeelen d. Am J Med. 1989 Sep 18;87(3C):41S-45S. doi: 10.1016/0002-9343(89)90505-6. Am J Med. 1989. PMID: 2782326

4

Improvement of anemia with deferoxamine in hemodialysis patients with aluminum-induced bone disease.

Tielemans C, Collart F, Wens R, Smeyers-Verbeeke J, van Hooff I, Dratwa M, Verbeelen D. Tielemans C, et al. Among authors: verbeelen d. Clin Nephrol. 1985 Nov;24(5):237-41. Clin Nephrol. 1985. PMID: 4075595

5

Effect of hemodialysis on left ventricular function in uremic cardiomyopathy.

Verbeelen D, Bossuyt A. Verbeelen D, et al. N Engl J Med. 1980 Aug 28;303(9):523. doi: 10.1056/NEJM198008283030915. N Engl J Med. 1980. PMID: 7393299 No abstract available.

6

Thyroid dysfunction in patients on regular hemodialysis: evaluation of the stable intrathyroidal iodine pool, incidence of goiter and free thyroid hormone concentration.

Sennesael JJ, Verbeelen DL, Jonckheer MH. Sennesael JJ, et al. Among authors: verbeelen dl. Nephron. 1985;41(2):141-5. doi: 10.1159/000183569. Nephron. 1985. PMID: 3930977

7

Usefulness of 99mTc-methylene diphosphonate scintigraphy in nephrocalcinosis.

Bossuyt A, Verbeelen D, Jonckheer MH, Six R. Bossuyt A, et al. Among authors: verbeelen d. Clin Nucl Med. 1979 Aug;4(8):333-4. doi: 10.1097/00003072-197908000-00005. Clin Nucl Med. 1979. PMID: 466914

8

Evaluation of platelets and hemostasis during hemodialysis with six different membranes.

Verbeelen D, Jochmans K, Herman AG, Van der Niepen P, Sennesael J, De Waele M. Verbeelen D, et al. Nephron. 1991;59(4):567-72. doi: 10.1159/000186645. Nephron. 1991. PMID: 1766495 Clinical Trial.

9

Treatment of gram-negative peritonitis with aztreonam in patients undergoing continuous ambulatory peritoneal dialysis.

Dratwa M, Glupczynski Y, Lameire N, Matthys D, Verschraegen G, Vaneechoutte M, Boelaert J, Schurgers M, Van Landuyt H, Verbeelen D, et al. Dratwa M, et al. Among authors: verbeelen d. Rev Infect Dis. 1991 May-Jun;13 Suppl 7:S645-7. doi: 10.1093/clinids/13.supplement_7.s645. Rev Infect Dis. 1991. PMID: 2068475 Clinical Trial.

10

Red blood cells indices and aluminium toxicity in haemodialysis patients.

Tielemans C, Kalima L, Collart F, Wens R, Smeyers-Verbeke J, Verbeelen D, Dratwa M. Tielemans C, et al. Among authors: verbeelen d. Proc Eur Dial Transplant Assoc Eur Ren Assoc. 1985;21:395-8. Proc Eur Dial Transplant Assoc Eur Ren Assoc. 1985. PMID: 3991530

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

134 results

Search Page

Filters